The Only Complete Online Marketing Firm
Monday, April 25, 2016
Gliptin Users Don't Seem to Have Higher CV Risk (CME/CE)
(MedPage Today) -- FDA pilot study contradict earlier results for Onglyza, Januvia
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment